Literature DB >> 12918182

[Remission of chronic kidney diseases. A realistic goal?].

Gert Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918182     DOI: 10.1007/bf03040431

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  11 in total

1.  Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).

Authors:  Franz H Messerli; Mandeep R Mehra
Journal:  Am J Cardiol       Date:  2002-11-15       Impact factor: 2.778

Review 2.  Management of hypertensive crises: the scientific basis for treatment decisions.

Authors:  J D Blumenfeld; J H Laragh
Journal:  Am J Hypertens       Date:  2001-11       Impact factor: 2.689

3.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

Review 4.  [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].

Authors:  C Schwarz; R Oberbauer
Journal:  Wien Klin Wochenschr       Date:  2000-11-10       Impact factor: 1.704

5.  "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis.

Authors:  R D Toto; H C Mitchell; R D Smith; H C Lee; D McIntire; W A Pettinger
Journal:  Kidney Int       Date:  1995-09       Impact factor: 10.612

6.  Reversible renal failure in malignant hypertension.

Authors:  F T Cordingley; N F Jones; A J Wing; P J Hilton
Journal:  Clin Nephrol       Date:  1980-08       Impact factor: 0.975

Review 7.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

8.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

9.  Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension.

Authors:  S H James; A M Meyers; F J Milne; S G Reinach
Journal:  Nephron       Date:  1995       Impact factor: 2.847

10.  Regression of retinal vascular changes by antihypertensive therapy.

Authors:  K D Bock
Journal:  Hypertension       Date:  1984 Nov-Dec       Impact factor: 10.190

View more
  1 in total

1.  Severe but reversible hypertensive encephalopathy.

Authors:  Josef Kletzmayr; Martin Uffmann; Sabine Schmaldienst
Journal:  Wien Klin Wochenschr       Date:  2003-07-15       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.